Literature DB >> 31676316

Fibroblast-secreted trophic factors contribute with ECM remodeling stimulus and upmodulate osteocyte gene markers in osteoblasts.

Célio Jr da Costa Fernandes1, Willian Fernando Zambuzzi2.   

Abstract

As osteogenesis is a multifactorial mechanism, we wonder whether osteoblast-induced extracellular matrix (ECM) remodeling might be modulated by trophic factors released by fibroblasts in a paracrine signaling manner. To address this issue, fibroblasts were cultured for 72 h under conventional conditions when their conditioned medium was harvested and used to challenge pre-osteoblasts (MC3T3-E1 cells) for 14 days. Preliminarily, we validated the potential effect of fibroblasts in contributing to osteocyte phenotype, which specifically requires significant expression of Dentin Matrix Protein 1 (DMP1; about 10-fold changes) and Sclerostin (SOST; about 7-fold changes), both biomarkers of osteocyte. Fibroblasts also seem contributing to ECM remodeling in osteoblasts, because we detected a high level of both mRNA and enzyme activities of matrix metalloproteinase -9 (MMP-9) as well as a high level of reversion inducing cysteine rich protein with kazal motifs (RECK) transcripts (about 13-fold changes), a membrane-anchored MMP inhibitor, which seems to be a constitutive pathway in osteoblasts. Considering inflammatory panorama and using RTqPCR technology, both IL-13 (about 13-fold changes) and IL-33 (about 5-fold changes) genes were up-expressed in response to the fibroblast-secreted trophic factors, as were the receptor activator of NF-κB ligand (RANKL; about 8-fold changes) and osteoprotegerin (OPG; about 3-fold changes). Although preliminary, these data suggest a stimulus to finely control osteoclastogenesis, and this mechanism reinforces the role of fibroblasts in bone remodeling and homeostasis. Moreover, these results suggest an important crosstalk between fibroblast and osteoblast, when fibroblast-secreted trophic factors upmodulate osteocyte gene markers and contribute to ECM remodeling stimulus in osteoblast.
Copyright © 2019 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Bone; Crosstalk; Extracellular matrix; Fibroblast; Osteoblast; Osteocyte

Mesh:

Substances:

Year:  2019        PMID: 31676316     DOI: 10.1016/j.biochi.2019.10.013

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  4 in total

1.  Corticotropin releasing hormone as an identifier of bronchiolitis obliterans syndrome.

Authors:  Anna Niroomand; Haider Ghaidan; Oskar Hallgren; Lennart Hansson; Hillevi Larsson; Darcy Wagner; Martina Mackova; Kieran Halloran; Snejana Hyllén; Sandra Lindstedt
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

2.  Cystatin-like protein of sweet orange (CsinCPI-2) modulates pre-osteoblast differentiation via β-Catenin involvement.

Authors:  Willian Fernando Zambuzzi; Gisele Faria; Célio da Costa Fernandes; Victor Manuel Ochoa Rodríguez; Andrea Soares-Costa; Joni Augusto Cirelli; Daniela Morilha Neo Justino; Bárbara Roma
Journal:  J Mater Sci Mater Med       Date:  2021-03-22       Impact factor: 3.896

3.  Nanohydroxyapatite-Blasted Bioactive Surface Drives Shear-Stressed Endothelial Cell Growth and Angiogenesis.

Authors:  T S Pinto; B R Martins; M R Ferreira; F Bezerra; W F Zambuzzi
Journal:  Biomed Res Int       Date:  2022-02-23       Impact factor: 3.411

4.  MMP-2 salivary activity in type 2 diabetes mellitus patients.

Authors:  Juan Antonio Arreguin-Cano; Brenda Ayerdi-Nájera; Arvey Tacuba-Saavedra; Napoleón Navarro-Tito; Alfonso Dávalos-Martínez; Abel Emigdio-Vargas; Elia Barrera-Rodríguez; Nubia Blanco-García; Gloria Gutiérrez-Venegas; Elías Ventura-Molina; Gladys León-Dorantes
Journal:  Diabetol Metab Syndr       Date:  2019-12-30       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.